Eugene

Scaled Eugene from approximately $40k monthly revenue to nearly half a million dollars per month while maintaining highly efficient MERs within a high-cost clinical environment. Revenue growth accelerated year-on-year with +20% growth in 2023, +68% in 2024, and +102% in 2025, while operating with a single part-time junior coordinator and fully in-house marketing operations. Led go-to-market strategies for 21+ Medicare-backed reproductive screening products, helping shape adoption and patient demand across Australia.